GO
Loading...

Medtronic Inc

More

  • Justices Make It Harder to Sue Medical Device Makers Wednesday, 20 Feb 2008 | 11:19 AM ET

    The Supreme Court on Wednesday made it harder for consumers to sue manufacturers of federally approved medical devices.

  • Stock Gains Evaporate After Oil Hits $100 Tuesday, 19 Feb 2008 | 4:55 PM ET

    Stock gains evaporated Tuesday after oil prices hit $100 a barrel.

  • Stocks Bounce After Housing Report Tuesday, 19 Feb 2008 | 2:00 PM ET

    U.S. stocks opened higher Tuesday, led by energy as supply disruptions boosted oil prices.

  • Energy Stocks Lead Dow Higher Tuesday, 19 Feb 2008 | 11:13 AM ET

    U.S. stocks opened higher Tuesday, led by energy as supply disruptions boosted oil prices.

  • What's an Investor to Do? Recession-Proof Stocks Tuesday, 5 Feb 2008 | 3:35 PM ET

    Investors are worried about a recession again.  So  CNBC asked the experts for some recession-proof stock picks.

  • Medical Device Makers: Healthy Buys Tuesday, 5 Feb 2008 | 3:01 PM ET

    The medical device field has its problems -- but Jan Wald thinks the stocks of medical device makers may be excellent defensive plays in the current market environment. "Valuations of these stocks are pretty low at this point," the Stanford Group managing director told CNBC...

  • Boston Scientific And The "Struggling" Stents Tuesday, 5 Feb 2008 | 10:25 AM ET

    Sales of drug-coated stents, Boston Scientific's most profitable products, came in at the low end of the company's guidance in the fourth quarter. Stents are the fragile little wire mesh cylinders that act like scaffolding to prop open clogged arteries.

  • Stocks On The Move: Medtronic, Flowserve... Friday, 1 Feb 2008 | 6:46 PM ET

    Following are the week’s biggest winners and losers. Find out why shares of Medtronic (MDT) and Flowserve (FLS) popped while Merck (MRK) and Callaway Golf (ELY) dropped.

  • Stocks Have a Super Week Friday, 1 Feb 2008 | 4:48 PM ET

    Stocks closed higher as investors appeared more enthused about Microsoft's bid for Yahoo! than they were concerned about the latest signs of economic weakness. The three major indexes each gained about 3-4 percent for the week, but the market still has a way to go to recover from January's rout.

  • Medtronic Gets Approval for Drug-Coated Stent Friday, 1 Feb 2008 | 4:36 PM ET

    Medtronic on Friday received federal approval to sell its drug-coated stent, the first to hit the U.S. market since safety concerns sank their popularity two years ago.

  • My 7 For '07: The Pharma Year in Review Friday, 28 Dec 2007 | 1:57 PM ET

    The seven biggest stories in my sectors in 2007? Avandia, Dendreon, Pfizer, Biogen were just a few of the topics that made this a fascinating year for the pharmaceuticals and biotechnology industries.

  • Friday's Playbook Thursday, 27 Dec 2007 | 7:29 PM ET

    Like precision radar, The Fast Money Five zero in on three hot trades. Find out how they're playing excessive write-downs, a highly anticipated decision from the FDA and avoiding a visit from the tax man!

  • US Panel Backs Abbott's Drug-Coated Heart Stent Thursday, 29 Nov 2007 | 9:18 PM ET

    Abbott Laboratories moved closer to joining the U.S. market for drug-coated heart stents on Thursday as an advisory panel backed the company's experimental device.

  • Stocks End Higher After Another Wild Session Tuesday, 20 Nov 2007 | 5:02 PM ET

    Stocks closed higher after another volatile session, helped by a rally among energy shares as oil soared to a record high close of $98 a barrel.

  • Medtronic Shares Climb as Recall Shrugged Off Tuesday, 20 Nov 2007 | 2:24 PM ET

    Shares of medical device maker Medtronic rose Tuesday after Wall Street shrugged off a 2 percent dip in the company's second-quarter profit on the recall of Sprint Fidelis heart wires.

  • Medtronic Profit Down 2% But Tops Estimates Monday, 19 Nov 2007 | 5:08 PM ET

    Medtronic on Monday said quarterly profit fell 2 percent from a year ago, as the recall of a component used with its implantable devices to treat abnormal heart rhythms hurt revenue.

  • St. Jude Shocked Back to Life Friday, 16 Nov 2007 | 6:51 PM ET

    A false report about a key product nearly killed this stock. But it looks like STJ is in full recovery now.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.

  • Lightning Round: Rite Aid, VMware, Arthrocare and More Thursday, 15 Nov 2007 | 7:20 PM ET

    Cramer makes the call on viewers' favorite stocks.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.

  • Dow Ends Below 14,000 as Financial Stocks Slump Monday, 15 Oct 2007 | 4:00 PM ET

    Stocks closed lower after financial giant Citigroup halted its stock buyback plan and said it and two other big U.S. banks will create a multibillion-dollar fund in order to support the struggling commercial debt market.

  • Medtronic Suspends Distribution of Heart Device Monday, 15 Oct 2007 | 11:57 AM ET

    Medtronic said on Monday that its move to suspend sales of a heart device would hurt revenue by $150 million to $250 million in the second quarter.

Most Popular Video

Wednesday, 16 Apr 2014 | 12:00 AM ET

GM unveils new models, hopes for strong sales this year After massive recalls, General Motors is pushing forward with new car models unveiled at the 2014 New York International Auto Show. CNBC's Phil LeBeau explains.

Friday, 11 Apr 2014 | 7:23 AM ET

Former Fed Chairman Ben Bernanke challenges Raghuram Rajan, Reserve Bank of India governor on his views about monetary policies, reports CNBC's Michelle Caruso-Cabrera.

Tuesday, 15 Apr 2014 | 5:40 PM ET

Jonathan Geller, BGR president and editor-in-chief, weighs in on the specifications for Amazon's newly announced 3-D smartphone.